Document is current
Any future updates will be listed below
-
Authors
Jimenez-Garcia, Celia
Perula-de Torres, Luis Angel http://orcid.org/0000-0002-8784-4905
Villegas-Becerril, Enrique
Muñoz-Gavilan, Juan Jose
Espinosa-Calvo, Maria
Montes-Redondo, Gertrudis
Romero-Rodriguez, Esperanza
,
Manzanaro, Maria Carmen Moreno
Santiago, Fatima Ginés
Serrano, Carmen Bueno
Ruperto, Fabiola Romero
Ramirez, Maria Cruz Linares
Román, Maria Angeles Quesada
Alcaraz, Nieves Muñoz
Rejano, Juan Manuel Parras
Estepa, Maria Isabel Lopez
Maestre-Serrano, Maria Dolores
Villatoro, Jaime Monserrat
-
Funding
Funding for this research was provided by:
Fundación Pública Andaluza Progreso y Salud (AP-0235-2019)
- License Information
-
More Information
Article History
Received: 28 March 2023
Accepted: 1 January 2024
First Online: 25 January 2024
Declarations
:
: The Clinical Research and Ethics Committee of the Reina Sofia Hospital in Cordoba (Spain) approved the protocol for this clinical trial (reference number 4430, dated 03/12/2019). Signed written informed consent from each participant was obtained following the general recommendations of the Helsinki Declaration. All participants were informed about the purpose of the study and the risks and benefits. Confidentiality of the participants’ data will be guaranteed at all times under the provisions of Organic Law 3/2018, on the Protection of Personal Data and the Guarantee of Digital Rights, Law 14/2007r, on Biomedical Research, and Regulation 2016/679 of the European Parliament and of the Council on the General Protection of Personal Data about the processing of personal data and the free movement of such data.
: Enrique Villegas Becerril claims to be one of the inventors of the Alantel© cream. The remaining authors declare that they have no competing interests.
